500770-75-2 Usage
Uses
Used in Pharmaceutical Industry:
Boc-(S)-3-amino-3-(2-bromo-phenyl)-propionic acid is used as a synthetic intermediate for the development of new pharmaceutical compounds. Its unique structure allows for the creation of novel drug candidates with potential therapeutic applications.
Used in Peptide Synthesis:
In the field of peptide synthesis, Boc-(S)-3-amino-3-(2-bromo-phenyl)-propionic acid is used as a building block. The Boc protective group is crucial in this context, as it prevents unwanted side reactions during the synthesis process, ensuring the production of the desired peptide sequence.
Used in Chemical Research:
Boc-(S)-3-amino-3-(2-bromo-phenyl)-propionic acid is employed as a research tool in chemical laboratories. Its distinctive structure and reactivity make it a valuable compound for studying various chemical reactions and mechanisms, contributing to the advancement of synthetic chemistry.
Used in Material Science:
In material science, Boc-(S)-3-amino-3-(2-bromo-phenyl)-propionic acid is used as a component in the synthesis of new materials with tailored properties. The introduction of the bromophenyl group can influence the electronic and steric characteristics of the resulting materials, opening up possibilities for applications in areas such as electronics, coatings, and adhesives.
Check Digit Verification of cas no
The CAS Registry Mumber 500770-75-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,0,7,7 and 0 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 500770-75:
(8*5)+(7*0)+(6*0)+(5*7)+(4*7)+(3*0)+(2*7)+(1*5)=122
122 % 10 = 2
So 500770-75-2 is a valid CAS Registry Number.
InChI:InChI=1/C14H18BrNO4/c1-14(2,3)20-13(19)16-11(8-12(17)18)9-6-4-5-7-10(9)15/h4-7,11H,8H2,1-3H3,(H,16,19)(H,17,18)
500770-75-2Relevant academic research and scientific papers
2-METHYL-QUINAZOLINES
-
Page/Page column 400, (2018/10/19)
The present invention describes 2-methyl-quinazoline compounds of general formula (I), methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions. The 2-methyl substituted quinazoline compounds of general formula(I) effectively and selectively inhibit the Ras-Sos interaction without significantly targeting the EGFR receptor. They are therefore useful for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, such as cancer as a sole agent or in combination with other active ingredients.
